Article

Dr. Patrick P. Gleason Addresses the Impact of Out-of-Pocket Costs on Adherence and Outcomes

Patrick P. Gleason, PharmD, Director of Clinical Outcomes Assessment, Prime Therapeutics, discusses the rates at which patients will not follow a prescribed therapeutic plan due to cost-sharing. Specifically, patients starting multiple sclerosis, rheumatoid arthritis, and oral oncology medication regimens with more than a $100 cost-share will be less likely to start the drug therapy.

Patrick P. Gleason, PharmD, Director of Clinical Outcomes Assessment, Prime Therapeutics, discusses the rates at which patients will not follow a prescribed therapeutic plan due to cost-sharing. Specifically, patients starting multiple sclerosis, rheumatoid arthritis, and oral oncology medication regimens with more than a $100 cost-share will be less likely to start the drug therapy.

Related Videos
Bridgette J. Picou, LVN, ACLPN, The Well Project
Mia Moore, PhD, Fred Hutch Cancer Center
rachel rohaidy
Steven Daniel Daveluy, MD, FAAD
Shawn Kwatra, MD, FAAD
Dr Xin Hu
Elizabeth Jones, MD, FAAD.
Tiffany Meng, PharmD, oncology pharmacist with UCSF Health
Brittany Craiglow, MD, FAAD
Related Content
Person pushing button with slight frowning face | Image credit: EDER – stock.adobe.com
March 11th 2025

Americans Give US Health Care System a C Grade, Calling for Policy Change

Hayden E. Klein
A new report shows most Americans believe the government is too involved in health care regulation and want to see a ban on pharmaceutical company advertisements in the US.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Nadine Barrett, PhD, MS, MPH | Image: Wake Forest
March 7th 2025

Barrett and Zon: Lessons in Leadership, Challenges in Cancer Care

Mary Caffrey
A discussion with the presidents of the Association of Cancer Care Centers (ACCC) and the American Society of Clinical Oncology took place at the ACCC 51st Annual Meeting & Cancer Center Business Summit.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
The report estimates that the loss of enhanced PTCs would lead to a $26.1 billion reduction in federal tax credits given to individuals, health insurers, and in turn, health care providers. | Image credit: onephoto - stock.adobe.com
March 6th 2025

Eliminating Enhanced PTCs Would Have Cascading Economic Impacts, Report Estimates

Rose McNulty
Enhanced premium tax credits (PTCs) have made marketplace health insurance more affordable, and eliminating them could have sweeping impacts on consumers and the health care industry, according to a new report.
Senate | Image Credit: Corgarashu - stock.adobe.com
March 5th 2025

Senate Questions NIH Nominee on Funding, Transparency, and COVID-19 Impact

Pearl Steinzor
Jay Bhattacharya, MD, PhD, defended his vision for the National Institutes of Health in a Senate committee confirmation hearing, tackling concerns on research funding, public trust, and scientific integrity.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo